Metraipolis › archive › dc_0696b1cd6fe7
Assessing high-throughput surrogate assays for real-world HPV16- and HPV18-specific vaccine immune monitoring: a comparison of PBNA, cCLIA, and IgG — Europe PMC PMID:42774225
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/42774225
- DOI
- 10.3389/fimmu.2026.1923707
- License (as archived)
- solo-consultazione
- Archived
- 2026-10-15T21:41:12.346Z
- SHA-256 of the archived text
7fffe29cb6fc3f9dd2c02ebdfb7f1ecd70cca89b844b552bb91a9d9a132853ad- Stable URL of this page
https://metraipolis.com/documento/dc_0696b1cd6fe7
How to cite
Assessing high-throughput surrogate assays for real-world HPV16- and HPV18-specific vaccine immune monitoring: a comparison of PBNA, cCLIA, and IgG — Europe PMC PMID:42774225 — Europe PMC (en), https://europepmc.org/article/MED/42774225 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_0696b1cd6fe7 (Metraipolis archive dc_0696b1cd6fe7, sha256 7fffe29cb6fc3f9dd2c02ebdfb7f1ecd70cca89b844b552bb91a9d9a132853ad)
BibTeX
@misc{dc0696b1cd6fe7,
title = {Assessing high-throughput surrogate assays for real-world HPV16- and HPV18-specific vaccine immune monitoring: a comparison of PBNA, cCLIA, and IgG — Europe PMC PMID:42774225},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/42774225},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_0696b1cd6fe7; sha256 7fffe29cb6fc3f9dd2c02ebdfb7f1ecd70cca89b844b552bb91a9d9a132853ad},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42774225. Agents can read the archived copy with the MCP tool read_document.